Hanley Conor

SEC Form 4 insider trading activity

Hanley Conor has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.

On the most recent filing, Hanley Conor is listed as Director at KESTRA MEDICAL TECHNOLOGIES, LTD. Inside the rolling window, Hanley Conor reported no open-market purchases and 1 open-market sale totaling $144K in KMTS.

Companies traded

Other insiders at KMTS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$144K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
KMTS
Hanley Conor
Sale$144KSep 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Hanley Conor made?

Hanley Conor has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.

Which companies does Hanley Conor trade?

Hanley Conor has filed SEC Form 4 disclosures for 1 company, including KMTS.

When was Hanley Conor's most recent SEC Form 4 filing?

Hanley Conor's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.

What is Hanley Conor's total buy and sell value in the current window?

Inside the rolling retention window, Hanley Conor bought $0 and sold $144K based on SEC Form 4 filings.

What was Hanley Conor's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 5,694 KMTS shares on 2026-09-08, worth $144K, per SEC Form 4 filings.